nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP2A6—Methoxsalen—psoriasis	0.182	0.303	CbGbCtD
Pilocarpine—CYP2A6—Prednisolone—psoriasis	0.0885	0.147	CbGbCtD
Pilocarpine—CYP2A6—Dexamethasone—psoriasis	0.0522	0.0867	CbGbCtD
Pilocarpine—CYP3A4—Calcitriol—psoriasis	0.0468	0.0778	CbGbCtD
Pilocarpine—CYP3A4—Methoxsalen—psoriasis	0.0364	0.0605	CbGbCtD
Pilocarpine—CYP2E1—Dexamethasone—psoriasis	0.0344	0.0572	CbGbCtD
Pilocarpine—CYP3A4—Cholecalciferol—psoriasis	0.0241	0.0401	CbGbCtD
Pilocarpine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0209	0.0347	CbGbCtD
Pilocarpine—CYP3A4—Triamcinolone—psoriasis	0.0209	0.0347	CbGbCtD
Pilocarpine—CYP3A4—Betamethasone—psoriasis	0.0179	0.0298	CbGbCtD
Pilocarpine—CYP3A4—Prednisolone—psoriasis	0.0177	0.0294	CbGbCtD
Pilocarpine—CYP3A4—Hydrocortisone—psoriasis	0.0168	0.0279	CbGbCtD
Pilocarpine—CYP3A4—Prednisone—psoriasis	0.0167	0.0278	CbGbCtD
Pilocarpine—CYP3A4—Cyclosporine—psoriasis	0.0158	0.0263	CbGbCtD
Pilocarpine—CYP3A4—Dexamethasone—psoriasis	0.0104	0.0173	CbGbCtD
Pilocarpine—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.00118	0.122	CbGpPWpGaD
Pilocarpine—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.000934	0.0966	CbGpPWpGaD
Pilocarpine—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.000732	0.0758	CbGpPWpGaD
Pilocarpine—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.000579	0.0599	CbGpPWpGaD
Pilocarpine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000304	0.0315	CbGpPWpGaD
Pilocarpine—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.0003	0.0311	CbGpPWpGaD
Pilocarpine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000268	0.0278	CbGpPWpGaD
Pilocarpine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000246	0.0255	CbGpPWpGaD
Pilocarpine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00024	0.0249	CbGpPWpGaD
Pilocarpine—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000237	0.0245	CbGpPWpGaD
Pilocarpine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000195	0.0202	CbGpPWpGaD
Pilocarpine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.00019	0.0197	CbGpPWpGaD
Pilocarpine—Constipation—Cyclosporine—psoriasis	0.000135	0.000346	CcSEcCtD
Pilocarpine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000134	0.000343	CcSEcCtD
Pilocarpine—Anorexia—Hydrocortisone—psoriasis	0.000133	0.000343	CcSEcCtD
Pilocarpine—Diarrhoea—Mycophenolic acid—psoriasis	0.000133	0.000343	CcSEcCtD
Pilocarpine—Stomatitis—Methotrexate—psoriasis	0.000133	0.000342	CcSEcCtD
Pilocarpine—Conjunctivitis—Methotrexate—psoriasis	0.000133	0.000341	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000133	0.000341	CcSEcCtD
Pilocarpine—Oedema—Triamcinolone—psoriasis	0.000132	0.000339	CcSEcCtD
Pilocarpine—Syncope—Dexamethasone—psoriasis	0.000131	0.000338	CcSEcCtD
Pilocarpine—Syncope—Betamethasone—psoriasis	0.000131	0.000338	CcSEcCtD
Pilocarpine—Constipation—Mycophenolate mofetil—psoriasis	0.000131	0.000338	CcSEcCtD
Pilocarpine—Pain—Mycophenolate mofetil—psoriasis	0.000131	0.000338	CcSEcCtD
Pilocarpine—Arrhythmia—Prednisone—psoriasis	0.000131	0.000337	CcSEcCtD
Pilocarpine—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000131	0.0136	CbGpPWpGaD
Pilocarpine—Infection—Triamcinolone—psoriasis	0.000131	0.000337	CcSEcCtD
Pilocarpine—Sweating—Methotrexate—psoriasis	0.000131	0.000336	CcSEcCtD
Pilocarpine—Hypotension—Hydrocortisone—psoriasis	0.000131	0.000336	CcSEcCtD
Pilocarpine—Haematuria—Methotrexate—psoriasis	0.00013	0.000335	CcSEcCtD
Pilocarpine—Feeling abnormal—Cyclosporine—psoriasis	0.00013	0.000334	CcSEcCtD
Pilocarpine—Shock—Triamcinolone—psoriasis	0.00013	0.000333	CcSEcCtD
Pilocarpine—Insomnia—Prednisolone—psoriasis	0.00013	0.000333	CcSEcCtD
Pilocarpine—Alopecia—Prednisone—psoriasis	0.00013	0.000333	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000129	0.000331	CcSEcCtD
Pilocarpine—Loss of consciousness—Betamethasone—psoriasis	0.000129	0.000331	CcSEcCtD
Pilocarpine—Loss of consciousness—Dexamethasone—psoriasis	0.000129	0.000331	CcSEcCtD
Pilocarpine—Dizziness—Mycophenolic acid—psoriasis	0.000129	0.000331	CcSEcCtD
Pilocarpine—Epistaxis—Methotrexate—psoriasis	0.000129	0.000331	CcSEcCtD
Pilocarpine—Paraesthesia—Prednisolone—psoriasis	0.000129	0.000331	CcSEcCtD
Pilocarpine—Tachycardia—Triamcinolone—psoriasis	0.000129	0.000331	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000128	0.000328	CcSEcCtD
Pilocarpine—Hyperhidrosis—Triamcinolone—psoriasis	0.000127	0.000328	CcSEcCtD
Pilocarpine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000127	0.000326	CcSEcCtD
Pilocarpine—Insomnia—Hydrocortisone—psoriasis	0.000127	0.000326	CcSEcCtD
Pilocarpine—Hypertension—Dexamethasone—psoriasis	0.000126	0.000325	CcSEcCtD
Pilocarpine—Hypertension—Betamethasone—psoriasis	0.000126	0.000325	CcSEcCtD
Pilocarpine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000126	0.0131	CbGpPWpGaD
Pilocarpine—Paraesthesia—Hydrocortisone—psoriasis	0.000126	0.000323	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000126	0.000323	CcSEcCtD
Pilocarpine—Myalgia—Dexamethasone—psoriasis	0.000125	0.000321	CcSEcCtD
Pilocarpine—Myalgia—Betamethasone—psoriasis	0.000125	0.000321	CcSEcCtD
Pilocarpine—Abdominal pain—Cyclosporine—psoriasis	0.000124	0.00032	CcSEcCtD
Pilocarpine—Body temperature increased—Cyclosporine—psoriasis	0.000124	0.00032	CcSEcCtD
Pilocarpine—Anxiety—Betamethasone—psoriasis	0.000124	0.00032	CcSEcCtD
Pilocarpine—Anxiety—Dexamethasone—psoriasis	0.000124	0.00032	CcSEcCtD
Pilocarpine—Vomiting—Mycophenolic acid—psoriasis	0.000124	0.000318	CcSEcCtD
Pilocarpine—Discomfort—Betamethasone—psoriasis	0.000123	0.000317	CcSEcCtD
Pilocarpine—Discomfort—Dexamethasone—psoriasis	0.000123	0.000317	CcSEcCtD
Pilocarpine—Dyspepsia—Hydrocortisone—psoriasis	0.000123	0.000317	CcSEcCtD
Pilocarpine—Rash—Mycophenolic acid—psoriasis	0.000123	0.000316	CcSEcCtD
Pilocarpine—Dermatitis—Mycophenolic acid—psoriasis	0.000123	0.000315	CcSEcCtD
Pilocarpine—Pain—Prednisolone—psoriasis	0.000123	0.000315	CcSEcCtD
Pilocarpine—Hepatitis—Methotrexate—psoriasis	0.000122	0.000315	CcSEcCtD
Pilocarpine—Headache—Mycophenolic acid—psoriasis	0.000122	0.000314	CcSEcCtD
Pilocarpine—Decreased appetite—Hydrocortisone—psoriasis	0.000122	0.000313	CcSEcCtD
Pilocarpine—Pharyngitis—Methotrexate—psoriasis	0.000122	0.000313	CcSEcCtD
Pilocarpine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000121	0.0126	CbGpPWpGaD
Pilocarpine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000121	0.000312	CcSEcCtD
Pilocarpine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000121	0.000312	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000121	0.000311	CcSEcCtD
Pilocarpine—Vision blurred—Prednisone—psoriasis	0.00012	0.000309	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.00012	0.000309	CcSEcCtD
Pilocarpine—Pain—Hydrocortisone—psoriasis	0.00012	0.000308	CcSEcCtD
Pilocarpine—Oedema—Dexamethasone—psoriasis	0.00012	0.000307	CcSEcCtD
Pilocarpine—Oedema—Betamethasone—psoriasis	0.00012	0.000307	CcSEcCtD
Pilocarpine—Insomnia—Triamcinolone—psoriasis	0.000119	0.000307	CcSEcCtD
Pilocarpine—Infection—Dexamethasone—psoriasis	0.000119	0.000305	CcSEcCtD
Pilocarpine—Infection—Betamethasone—psoriasis	0.000119	0.000305	CcSEcCtD
Pilocarpine—Paraesthesia—Triamcinolone—psoriasis	0.000118	0.000304	CcSEcCtD
Pilocarpine—Feeling abnormal—Prednisolone—psoriasis	0.000118	0.000304	CcSEcCtD
Pilocarpine—Visual impairment—Methotrexate—psoriasis	0.000118	0.000304	CcSEcCtD
Pilocarpine—Shock—Dexamethasone—psoriasis	0.000118	0.000303	CcSEcCtD
Pilocarpine—Shock—Betamethasone—psoriasis	0.000118	0.000303	CcSEcCtD
Pilocarpine—Dyspnoea—Triamcinolone—psoriasis	0.000117	0.000302	CcSEcCtD
Pilocarpine—Agitation—Prednisone—psoriasis	0.000117	0.000302	CcSEcCtD
Pilocarpine—Thrombocytopenia—Betamethasone—psoriasis	0.000117	0.000301	CcSEcCtD
Pilocarpine—Thrombocytopenia—Dexamethasone—psoriasis	0.000117	0.000301	CcSEcCtD
Pilocarpine—Tachycardia—Betamethasone—psoriasis	0.000117	0.0003	CcSEcCtD
Pilocarpine—Tachycardia—Dexamethasone—psoriasis	0.000117	0.0003	CcSEcCtD
Pilocarpine—Hypersensitivity—Cyclosporine—psoriasis	0.000116	0.000298	CcSEcCtD
Pilocarpine—Dyspepsia—Triamcinolone—psoriasis	0.000116	0.000298	CcSEcCtD
Pilocarpine—CHRM1—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000116	0.012	CbGpPWpGaD
Pilocarpine—Nausea—Mycophenolic acid—psoriasis	0.000116	0.000297	CcSEcCtD
Pilocarpine—Hyperhidrosis—Betamethasone—psoriasis	0.000116	0.000297	CcSEcCtD
Pilocarpine—Hyperhidrosis—Dexamethasone—psoriasis	0.000116	0.000297	CcSEcCtD
Pilocarpine—CHRM3—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000115	0.0119	CbGpPWpGaD
Pilocarpine—Feeling abnormal—Hydrocortisone—psoriasis	0.000115	0.000297	CcSEcCtD
Pilocarpine—Eye disorder—Methotrexate—psoriasis	0.000114	0.000294	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000114	0.000294	CcSEcCtD
Pilocarpine—Syncope—Prednisone—psoriasis	0.000114	0.000294	CcSEcCtD
Pilocarpine—CHRM2—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000114	0.0118	CbGpPWpGaD
Pilocarpine—Tinnitus—Methotrexate—psoriasis	0.000114	0.000294	CcSEcCtD
Pilocarpine—Anorexia—Dexamethasone—psoriasis	0.000114	0.000293	CcSEcCtD
Pilocarpine—Anorexia—Betamethasone—psoriasis	0.000114	0.000293	CcSEcCtD
Pilocarpine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000113	0.000291	CcSEcCtD
Pilocarpine—Asthenia—Cyclosporine—psoriasis	0.000113	0.000291	CcSEcCtD
Pilocarpine—Pain—Triamcinolone—psoriasis	0.000113	0.00029	CcSEcCtD
Pilocarpine—Loss of consciousness—Prednisone—psoriasis	0.000112	0.000288	CcSEcCtD
Pilocarpine—Hypotension—Betamethasone—psoriasis	0.000112	0.000287	CcSEcCtD
Pilocarpine—Hypotension—Dexamethasone—psoriasis	0.000112	0.000287	CcSEcCtD
Pilocarpine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000111	0.0115	CbGpPWpGaD
Pilocarpine—Pruritus—Cyclosporine—psoriasis	0.000111	0.000287	CcSEcCtD
Pilocarpine—Body temperature increased—Hydrocortisone—psoriasis	0.000111	0.000285	CcSEcCtD
Pilocarpine—Abdominal pain—Hydrocortisone—psoriasis	0.000111	0.000285	CcSEcCtD
Pilocarpine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00011	0.0114	CbGpPWpGaD
Pilocarpine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.00011	0.0114	CbGpPWpGaD
Pilocarpine—Asthenia—Mycophenolate mofetil—psoriasis	0.00011	0.000283	CcSEcCtD
Pilocarpine—Hypertension—Prednisone—psoriasis	0.00011	0.000283	CcSEcCtD
Pilocarpine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00011	0.0114	CbGpPWpGaD
Pilocarpine—Chills—Methotrexate—psoriasis	0.00011	0.000283	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000109	0.00028	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000109	0.00028	CcSEcCtD
Pilocarpine—Pruritus—Mycophenolate mofetil—psoriasis	0.000109	0.000279	CcSEcCtD
Pilocarpine—Myalgia—Prednisone—psoriasis	0.000109	0.000279	CcSEcCtD
Pilocarpine—Arthralgia—Prednisone—psoriasis	0.000109	0.000279	CcSEcCtD
Pilocarpine—Feeling abnormal—Triamcinolone—psoriasis	0.000109	0.000279	CcSEcCtD
Pilocarpine—Anxiety—Prednisone—psoriasis	0.000108	0.000278	CcSEcCtD
Pilocarpine—Alopecia—Methotrexate—psoriasis	0.000108	0.000278	CcSEcCtD
Pilocarpine—Insomnia—Betamethasone—psoriasis	0.000108	0.000278	CcSEcCtD
Pilocarpine—Insomnia—Dexamethasone—psoriasis	0.000108	0.000278	CcSEcCtD
Pilocarpine—Diarrhoea—Cyclosporine—psoriasis	0.000108	0.000277	CcSEcCtD
Pilocarpine—Paraesthesia—Betamethasone—psoriasis	0.000107	0.000276	CcSEcCtD
Pilocarpine—Paraesthesia—Dexamethasone—psoriasis	0.000107	0.000276	CcSEcCtD
Pilocarpine—Discomfort—Prednisone—psoriasis	0.000107	0.000276	CcSEcCtD
Pilocarpine—Hypersensitivity—Prednisolone—psoriasis	0.000106	0.000272	CcSEcCtD
Pilocarpine—Dyspepsia—Dexamethasone—psoriasis	0.000105	0.000271	CcSEcCtD
Pilocarpine—Dyspepsia—Betamethasone—psoriasis	0.000105	0.000271	CcSEcCtD
Pilocarpine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000105	0.00027	CcSEcCtD
Pilocarpine—CHRM2—G alpha (i) signalling events—HCAR2—psoriasis	0.000105	0.0108	CbGpPWpGaD
Pilocarpine—Dysgeusia—Methotrexate—psoriasis	0.000104	0.000269	CcSEcCtD
Pilocarpine—Body temperature increased—Triamcinolone—psoriasis	0.000104	0.000268	CcSEcCtD
Pilocarpine—Dizziness—Cyclosporine—psoriasis	0.000104	0.000268	CcSEcCtD
Pilocarpine—Oedema—Prednisone—psoriasis	0.000104	0.000268	CcSEcCtD
Pilocarpine—Decreased appetite—Betamethasone—psoriasis	0.000104	0.000267	CcSEcCtD
Pilocarpine—Decreased appetite—Dexamethasone—psoriasis	0.000104	0.000267	CcSEcCtD
Pilocarpine—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000103	0.0107	CbGpPWpGaD
Pilocarpine—Infection—Prednisone—psoriasis	0.000103	0.000266	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000103	0.000265	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000103	0.000265	CcSEcCtD
Pilocarpine—Back pain—Methotrexate—psoriasis	0.000103	0.000265	CcSEcCtD
Pilocarpine—Hypersensitivity—Hydrocortisone—psoriasis	0.000103	0.000265	CcSEcCtD
Pilocarpine—Shock—Prednisone—psoriasis	0.000102	0.000263	CcSEcCtD
Pilocarpine—Pain—Dexamethasone—psoriasis	0.000102	0.000263	CcSEcCtD
Pilocarpine—Pain—Betamethasone—psoriasis	0.000102	0.000263	CcSEcCtD
Pilocarpine—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000102	0.0106	CbGpPWpGaD
Pilocarpine—Tachycardia—Prednisone—psoriasis	0.000102	0.000261	CcSEcCtD
Pilocarpine—Dizziness—Mycophenolate mofetil—psoriasis	0.000102	0.000261	CcSEcCtD
Pilocarpine—Hyperhidrosis—Prednisone—psoriasis	0.000101	0.000259	CcSEcCtD
Pilocarpine—Vision blurred—Methotrexate—psoriasis	0.0001	0.000258	CcSEcCtD
Pilocarpine—Asthenia—Hydrocortisone—psoriasis	0.0001	0.000258	CcSEcCtD
Pilocarpine—Vomiting—Cyclosporine—psoriasis	0.0001	0.000257	CcSEcCtD
Pilocarpine—Rash—Cyclosporine—psoriasis	9.93e-05	0.000255	CcSEcCtD
Pilocarpine—Anorexia—Prednisone—psoriasis	9.93e-05	0.000255	CcSEcCtD
Pilocarpine—Dermatitis—Cyclosporine—psoriasis	9.92e-05	0.000255	CcSEcCtD
Pilocarpine—Pruritus—Hydrocortisone—psoriasis	9.9e-05	0.000255	CcSEcCtD
Pilocarpine—Headache—Cyclosporine—psoriasis	9.87e-05	0.000254	CcSEcCtD
Pilocarpine—Feeling abnormal—Dexamethasone—psoriasis	9.85e-05	0.000253	CcSEcCtD
Pilocarpine—Feeling abnormal—Betamethasone—psoriasis	9.85e-05	0.000253	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Dexamethasone—psoriasis	9.78e-05	0.000251	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Betamethasone—psoriasis	9.78e-05	0.000251	CcSEcCtD
Pilocarpine—Vomiting—Mycophenolate mofetil—psoriasis	9.77e-05	0.000251	CcSEcCtD
Pilocarpine—Hypersensitivity—Triamcinolone—psoriasis	9.71e-05	0.00025	CcSEcCtD
Pilocarpine—Rash—Mycophenolate mofetil—psoriasis	9.69e-05	0.000249	CcSEcCtD
Pilocarpine—Dermatitis—Mycophenolate mofetil—psoriasis	9.68e-05	0.000249	CcSEcCtD
Pilocarpine—Headache—Mycophenolate mofetil—psoriasis	9.62e-05	0.000247	CcSEcCtD
Pilocarpine—Diarrhoea—Hydrocortisone—psoriasis	9.58e-05	0.000246	CcSEcCtD
Pilocarpine—Leukopenia—Methotrexate—psoriasis	9.54e-05	0.000245	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Prednisone—psoriasis	9.49e-05	0.000244	CcSEcCtD
Pilocarpine—Dizziness—Prednisolone—psoriasis	9.48e-05	0.000244	CcSEcCtD
Pilocarpine—Asthenia—Triamcinolone—psoriasis	9.45e-05	0.000243	CcSEcCtD
Pilocarpine—Body temperature increased—Dexamethasone—psoriasis	9.45e-05	0.000243	CcSEcCtD
Pilocarpine—Body temperature increased—Betamethasone—psoriasis	9.45e-05	0.000243	CcSEcCtD
Pilocarpine—Abdominal pain—Dexamethasone—psoriasis	9.45e-05	0.000243	CcSEcCtD
Pilocarpine—Abdominal pain—Betamethasone—psoriasis	9.45e-05	0.000243	CcSEcCtD
Pilocarpine—Insomnia—Prednisone—psoriasis	9.42e-05	0.000242	CcSEcCtD
Pilocarpine—Nausea—Cyclosporine—psoriasis	9.35e-05	0.000241	CcSEcCtD
Pilocarpine—Paraesthesia—Prednisone—psoriasis	9.35e-05	0.00024	CcSEcCtD
Pilocarpine—Pruritus—Triamcinolone—psoriasis	9.32e-05	0.00024	CcSEcCtD
Pilocarpine—Cough—Methotrexate—psoriasis	9.3e-05	0.000239	CcSEcCtD
Pilocarpine—Dizziness—Hydrocortisone—psoriasis	9.25e-05	0.000238	CcSEcCtD
Pilocarpine—Dyspepsia—Prednisone—psoriasis	9.17e-05	0.000236	CcSEcCtD
Pilocarpine—Nausea—Mycophenolate mofetil—psoriasis	9.12e-05	0.000235	CcSEcCtD
Pilocarpine—Chest pain—Methotrexate—psoriasis	9.08e-05	0.000233	CcSEcCtD
Pilocarpine—Arthralgia—Methotrexate—psoriasis	9.08e-05	0.000233	CcSEcCtD
Pilocarpine—Myalgia—Methotrexate—psoriasis	9.08e-05	0.000233	CcSEcCtD
Pilocarpine—Decreased appetite—Prednisone—psoriasis	9.05e-05	0.000233	CcSEcCtD
Pilocarpine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	9.04e-05	0.00936	CbGpPWpGaD
Pilocarpine—Rash—Prednisolone—psoriasis	9.04e-05	0.000232	CcSEcCtD
Pilocarpine—Dermatitis—Prednisolone—psoriasis	9.03e-05	0.000232	CcSEcCtD
Pilocarpine—Headache—Prednisolone—psoriasis	8.98e-05	0.000231	CcSEcCtD
Pilocarpine—Discomfort—Methotrexate—psoriasis	8.97e-05	0.000231	CcSEcCtD
Pilocarpine—CYP2E1—Tryptophan metabolism—CAT—psoriasis	8.93e-05	0.00924	CbGpPWpGaD
Pilocarpine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	8.92e-05	0.00923	CbGpPWpGaD
Pilocarpine—Constipation—Prednisone—psoriasis	8.9e-05	0.000229	CcSEcCtD
Pilocarpine—Vomiting—Hydrocortisone—psoriasis	8.9e-05	0.000229	CcSEcCtD
Pilocarpine—Rash—Hydrocortisone—psoriasis	8.82e-05	0.000227	CcSEcCtD
Pilocarpine—Dermatitis—Hydrocortisone—psoriasis	8.82e-05	0.000227	CcSEcCtD
Pilocarpine—Confusional state—Methotrexate—psoriasis	8.77e-05	0.000226	CcSEcCtD
Pilocarpine—Headache—Hydrocortisone—psoriasis	8.77e-05	0.000225	CcSEcCtD
Pilocarpine—Dizziness—Triamcinolone—psoriasis	8.71e-05	0.000224	CcSEcCtD
Pilocarpine—Infection—Methotrexate—psoriasis	8.65e-05	0.000222	CcSEcCtD
Pilocarpine—Feeling abnormal—Prednisone—psoriasis	8.58e-05	0.000221	CcSEcCtD
Pilocarpine—Asthenia—Dexamethasone—psoriasis	8.58e-05	0.000221	CcSEcCtD
Pilocarpine—Asthenia—Betamethasone—psoriasis	8.58e-05	0.000221	CcSEcCtD
Pilocarpine—Thrombocytopenia—Methotrexate—psoriasis	8.52e-05	0.000219	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Prednisone—psoriasis	8.51e-05	0.000219	CcSEcCtD
Pilocarpine—Nausea—Prednisolone—psoriasis	8.51e-05	0.000219	CcSEcCtD
Pilocarpine—Pruritus—Betamethasone—psoriasis	8.46e-05	0.000218	CcSEcCtD
Pilocarpine—Pruritus—Dexamethasone—psoriasis	8.46e-05	0.000218	CcSEcCtD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	8.44e-05	0.00873	CbGpPWpGaD
Pilocarpine—Hyperhidrosis—Methotrexate—psoriasis	8.41e-05	0.000216	CcSEcCtD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	8.41e-05	0.00871	CbGpPWpGaD
Pilocarpine—Vomiting—Triamcinolone—psoriasis	8.38e-05	0.000215	CcSEcCtD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	8.33e-05	0.00862	CbGpPWpGaD
Pilocarpine—Nausea—Hydrocortisone—psoriasis	8.31e-05	0.000214	CcSEcCtD
Pilocarpine—Rash—Triamcinolone—psoriasis	8.31e-05	0.000214	CcSEcCtD
Pilocarpine—Dermatitis—Triamcinolone—psoriasis	8.3e-05	0.000213	CcSEcCtD
Pilocarpine—Anorexia—Methotrexate—psoriasis	8.3e-05	0.000213	CcSEcCtD
Pilocarpine—Headache—Triamcinolone—psoriasis	8.26e-05	0.000212	CcSEcCtD
Pilocarpine—Body temperature increased—Prednisone—psoriasis	8.23e-05	0.000212	CcSEcCtD
Pilocarpine—Abdominal pain—Prednisone—psoriasis	8.23e-05	0.000212	CcSEcCtD
Pilocarpine—Diarrhoea—Betamethasone—psoriasis	8.18e-05	0.00021	CcSEcCtD
Pilocarpine—Diarrhoea—Dexamethasone—psoriasis	8.18e-05	0.00021	CcSEcCtD
Pilocarpine—Hypotension—Methotrexate—psoriasis	8.13e-05	0.000209	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Methotrexate—psoriasis	7.93e-05	0.000204	CcSEcCtD
Pilocarpine—Dizziness—Dexamethasone—psoriasis	7.91e-05	0.000203	CcSEcCtD
Pilocarpine—Dizziness—Betamethasone—psoriasis	7.91e-05	0.000203	CcSEcCtD
Pilocarpine—Insomnia—Methotrexate—psoriasis	7.87e-05	0.000202	CcSEcCtD
Pilocarpine—Nausea—Triamcinolone—psoriasis	7.83e-05	0.000201	CcSEcCtD
Pilocarpine—Paraesthesia—Methotrexate—psoriasis	7.81e-05	0.000201	CcSEcCtD
Pilocarpine—Dyspnoea—Methotrexate—psoriasis	7.76e-05	0.0002	CcSEcCtD
Pilocarpine—Somnolence—Methotrexate—psoriasis	7.74e-05	0.000199	CcSEcCtD
Pilocarpine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.69e-05	0.00797	CbGpPWpGaD
Pilocarpine—Hypersensitivity—Prednisone—psoriasis	7.67e-05	0.000197	CcSEcCtD
Pilocarpine—Dyspepsia—Methotrexate—psoriasis	7.66e-05	0.000197	CcSEcCtD
Pilocarpine—Vomiting—Betamethasone—psoriasis	7.6e-05	0.000196	CcSEcCtD
Pilocarpine—Vomiting—Dexamethasone—psoriasis	7.6e-05	0.000196	CcSEcCtD
Pilocarpine—Decreased appetite—Methotrexate—psoriasis	7.56e-05	0.000195	CcSEcCtD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—RUNX3—psoriasis	7.55e-05	0.00782	CbGpPWpGaD
Pilocarpine—Rash—Dexamethasone—psoriasis	7.54e-05	0.000194	CcSEcCtD
Pilocarpine—Rash—Betamethasone—psoriasis	7.54e-05	0.000194	CcSEcCtD
Pilocarpine—Dermatitis—Betamethasone—psoriasis	7.53e-05	0.000194	CcSEcCtD
Pilocarpine—Dermatitis—Dexamethasone—psoriasis	7.53e-05	0.000194	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Methotrexate—psoriasis	7.51e-05	0.000193	CcSEcCtD
Pilocarpine—Headache—Dexamethasone—psoriasis	7.49e-05	0.000193	CcSEcCtD
Pilocarpine—Headache—Betamethasone—psoriasis	7.49e-05	0.000193	CcSEcCtD
Pilocarpine—Asthenia—Prednisone—psoriasis	7.47e-05	0.000192	CcSEcCtD
Pilocarpine—Pain—Methotrexate—psoriasis	7.44e-05	0.000191	CcSEcCtD
Pilocarpine—Pruritus—Prednisone—psoriasis	7.37e-05	0.000189	CcSEcCtD
Pilocarpine—CYP2A6—NRF2 pathway—TGFA—psoriasis	7.29e-05	0.00755	CbGpPWpGaD
Pilocarpine—Feeling abnormal—Methotrexate—psoriasis	7.17e-05	0.000184	CcSEcCtD
Pilocarpine—Diarrhoea—Prednisone—psoriasis	7.12e-05	0.000183	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Methotrexate—psoriasis	7.12e-05	0.000183	CcSEcCtD
Pilocarpine—Nausea—Betamethasone—psoriasis	7.1e-05	0.000183	CcSEcCtD
Pilocarpine—Nausea—Dexamethasone—psoriasis	7.1e-05	0.000183	CcSEcCtD
Pilocarpine—Dizziness—Prednisone—psoriasis	6.89e-05	0.000177	CcSEcCtD
Pilocarpine—Abdominal pain—Methotrexate—psoriasis	6.88e-05	0.000177	CcSEcCtD
Pilocarpine—Body temperature increased—Methotrexate—psoriasis	6.88e-05	0.000177	CcSEcCtD
Pilocarpine—Vomiting—Prednisone—psoriasis	6.62e-05	0.00017	CcSEcCtD
Pilocarpine—Rash—Prednisone—psoriasis	6.57e-05	0.000169	CcSEcCtD
Pilocarpine—Dermatitis—Prednisone—psoriasis	6.56e-05	0.000169	CcSEcCtD
Pilocarpine—Headache—Prednisone—psoriasis	6.52e-05	0.000168	CcSEcCtD
Pilocarpine—CHRM1—GPCR ligand binding—HCAR2—psoriasis	6.43e-05	0.00665	CbGpPWpGaD
Pilocarpine—Hypersensitivity—Methotrexate—psoriasis	6.41e-05	0.000165	CcSEcCtD
Pilocarpine—CHRM3—GPCR ligand binding—HCAR2—psoriasis	6.4e-05	0.00663	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—HCAR2—psoriasis	6.34e-05	0.00657	CbGpPWpGaD
Pilocarpine—Asthenia—Methotrexate—psoriasis	6.24e-05	0.000161	CcSEcCtD
Pilocarpine—Nausea—Prednisone—psoriasis	6.19e-05	0.000159	CcSEcCtD
Pilocarpine—Pruritus—Methotrexate—psoriasis	6.16e-05	0.000158	CcSEcCtD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—IL13—psoriasis	5.96e-05	0.00617	CbGpPWpGaD
Pilocarpine—Diarrhoea—Methotrexate—psoriasis	5.95e-05	0.000153	CcSEcCtD
Pilocarpine—Dizziness—Methotrexate—psoriasis	5.75e-05	0.000148	CcSEcCtD
Pilocarpine—Vomiting—Methotrexate—psoriasis	5.53e-05	0.000142	CcSEcCtD
Pilocarpine—Rash—Methotrexate—psoriasis	5.49e-05	0.000141	CcSEcCtD
Pilocarpine—Dermatitis—Methotrexate—psoriasis	5.48e-05	0.000141	CcSEcCtD
Pilocarpine—Headache—Methotrexate—psoriasis	5.45e-05	0.00014	CcSEcCtD
Pilocarpine—CHRM2—G alpha (i) signalling events—CCL20—psoriasis	5.44e-05	0.00563	CbGpPWpGaD
Pilocarpine—Nausea—Methotrexate—psoriasis	5.17e-05	0.000133	CcSEcCtD
Pilocarpine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.12e-05	0.0053	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	4.8e-05	0.00497	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	4.73e-05	0.0049	CbGpPWpGaD
Pilocarpine—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	4.67e-05	0.00483	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	4.38e-05	0.00454	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	4.37e-05	0.00452	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	4.33e-05	0.00448	CbGpPWpGaD
Pilocarpine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.14e-05	0.00429	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—IL10—psoriasis	3.73e-05	0.00386	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—HCAR2—psoriasis	3.63e-05	0.00376	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—HCAR2—psoriasis	3.62e-05	0.00375	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—HCAR2—psoriasis	3.58e-05	0.00371	CbGpPWpGaD
Pilocarpine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.57e-05	0.0037	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—CCL20—psoriasis	3.34e-05	0.00345	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—CCL20—psoriasis	3.33e-05	0.00344	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HCAR2—psoriasis	3.3e-05	0.00341	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—CCL20—psoriasis	3.29e-05	0.00341	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HCAR2—psoriasis	3.29e-05	0.0034	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HCAR2—psoriasis	3.25e-05	0.00337	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NDUFA5—psoriasis	2.63e-05	0.00273	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—LEP—psoriasis	2.54e-05	0.00263	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NDUFA5—psoriasis	2.47e-05	0.00256	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—NOS2—psoriasis	2.37e-05	0.00245	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP2S1—psoriasis	2.24e-05	0.00232	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—PPARG—psoriasis	2.21e-05	0.00229	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP2S1—psoriasis	2.1e-05	0.00217	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NDUFA5—psoriasis	2.08e-05	0.00215	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.04e-05	0.00211	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HCAR2—psoriasis	1.95e-05	0.00202	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HCAR2—psoriasis	1.94e-05	0.00201	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HCAR2—psoriasis	1.92e-05	0.00199	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—JUN—psoriasis	1.9e-05	0.00196	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—CCL20—psoriasis	1.89e-05	0.00195	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—CCL20—psoriasis	1.88e-05	0.00195	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—CCL20—psoriasis	1.86e-05	0.00193	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	1.84e-05	0.0019	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	1.83e-05	0.00189	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.82e-05	0.00189	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP2S1—psoriasis	1.77e-05	0.00183	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CCL20—psoriasis	1.71e-05	0.00177	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CCL20—psoriasis	1.71e-05	0.00177	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CCL20—psoriasis	1.69e-05	0.00175	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TAGAP—psoriasis	1.69e-05	0.00175	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TAGAP—psoriasis	1.68e-05	0.00174	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TAGAP—psoriasis	1.67e-05	0.00173	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.66e-05	0.00171	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—JUN—psoriasis	1.57e-05	0.00162	CbGpPWpGaD
Pilocarpine—CHRM2—G alpha (i) signalling events—CXCL8—psoriasis	1.47e-05	0.00152	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—TNF—psoriasis	1.42e-05	0.00147	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.18e-05	0.00123	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.18e-05	0.00122	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.17e-05	0.00121	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—IL6—psoriasis	1.15e-05	0.00119	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CARM1—psoriasis	1.09e-05	0.00113	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—TP53—psoriasis	1.04e-05	0.00107	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CARM1—psoriasis	1.03e-05	0.00106	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCL20—psoriasis	1.01e-05	0.00105	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCL20—psoriasis	1.01e-05	0.00104	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCL20—psoriasis	9.99e-06	0.00103	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NDUFA5—psoriasis	9.65e-06	0.000999	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—IL6—psoriasis	9.47e-06	0.000981	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—CXCL8—psoriasis	9.01e-06	0.000933	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—CXCL8—psoriasis	8.98e-06	0.00093	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	8.98e-06	0.000929	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	8.95e-06	0.000926	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—CXCL8—psoriasis	8.9e-06	0.000921	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CARM1—psoriasis	8.64e-06	0.000895	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2S1—psoriasis	8.21e-06	0.00085	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CAT—psoriasis	6.73e-06	0.000696	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CAT—psoriasis	6.31e-06	0.000653	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SOCS1—psoriasis	5.57e-06	0.000577	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SOCS1—psoriasis	5.55e-06	0.000575	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SOCS1—psoriasis	5.5e-06	0.000569	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CAT—psoriasis	5.32e-06	0.00055	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—TYK2—psoriasis	5.31e-06	0.00055	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—TYK2—psoriasis	5.3e-06	0.000548	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—TYK2—psoriasis	5.24e-06	0.000543	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—APOE—psoriasis	5.23e-06	0.000541	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—CXCL8—psoriasis	5.09e-06	0.000527	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—CXCL8—psoriasis	5.08e-06	0.000526	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	5.03e-06	0.00052	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—APOE—psoriasis	4.9e-06	0.000507	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CXCL8—psoriasis	4.62e-06	0.000479	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CXCL8—psoriasis	4.61e-06	0.000477	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CXCL8—psoriasis	4.57e-06	0.000473	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PPARG—psoriasis	4.55e-06	0.000471	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PPARG—psoriasis	4.27e-06	0.000442	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—APOE—psoriasis	4.13e-06	0.000428	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—APOE—psoriasis	4.11e-06	0.000426	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—LEP—psoriasis	4.11e-06	0.000426	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—APOE—psoriasis	4.1e-06	0.000424	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—LEP—psoriasis	4.1e-06	0.000424	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—LEP—psoriasis	4.06e-06	0.00042	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—APOE—psoriasis	4.06e-06	0.00042	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CARM1—psoriasis	4.01e-06	0.000415	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NFKBIA—psoriasis	3.83e-06	0.000397	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NFKBIA—psoriasis	3.82e-06	0.000395	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	3.78e-06	0.000392	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PPARG—psoriasis	3.6e-06	0.000372	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TYK2—psoriasis	3.14e-06	0.000325	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TYK2—psoriasis	3.13e-06	0.000324	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TYK2—psoriasis	3.1e-06	0.000321	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CXCL8—psoriasis	2.73e-06	0.000283	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CXCL8—psoriasis	2.72e-06	0.000282	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCL8—psoriasis	2.7e-06	0.000279	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL6—psoriasis	2.6e-06	0.000269	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL6—psoriasis	2.59e-06	0.000268	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL6—psoriasis	2.56e-06	0.000265	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—JUN—psoriasis	2.54e-06	0.000263	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—JUN—psoriasis	2.53e-06	0.000262	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JUN—psoriasis	2.51e-06	0.00026	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CAT—psoriasis	2.47e-06	0.000255	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NFKB1—psoriasis	2.44e-06	0.000253	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NFKB1—psoriasis	2.44e-06	0.000252	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NFKB1—psoriasis	2.41e-06	0.00025	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—VEGFA—psoriasis	2.22e-06	0.00023	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—VEGFA—psoriasis	2.21e-06	0.000229	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—STAT3—psoriasis	2.2e-06	0.000227	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—VEGFA—psoriasis	2.19e-06	0.000227	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—STAT3—psoriasis	2.19e-06	0.000227	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—STAT3—psoriasis	2.17e-06	0.000225	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APOE—psoriasis	1.92e-06	0.000198	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TP53—psoriasis	1.68e-06	0.000174	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TP53—psoriasis	1.67e-06	0.000173	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPARG—psoriasis	1.67e-06	0.000173	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TP53—psoriasis	1.66e-06	0.000171	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6—psoriasis	1.53e-06	0.000159	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6—psoriasis	1.53e-06	0.000158	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6—psoriasis	1.51e-06	0.000157	CbGpPWpGaD
